This one's for Charles, I know she is reading.

"Cumberland Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration (FDA) has extended its review of the supplemental new drug application (sNDA) for the use of Acetadote? (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure."